Abbott Laboratories
NYSE:ABT
Abbott Laboratories
NYSE:ABT
Price:
109.48 USD
0.54%
Updated:
Apr 16, 2024
Abbott Laboratories
Other Long-Term Assets
Last
Value
3-Years CAGR
5-Years CAGR
|
Abbott Laboratories
Other Long-Term Assets Peer Comparison
Comparables:
BDX
BSX
EW
SYK
ISRG
Competitive Other Long-Term Assets Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Long-Term Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Abbott Laboratories
NYSE:ABT
|
Other Long-Term Assets
$7.1B
|
CAGR 3-Years
24%
|
CAGR 5-Years
30%
|
CAGR 10-Years
13%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Other Long-Term Assets
$2.3B
|
CAGR 3-Years
8%
|
CAGR 5-Years
16%
|
CAGR 10-Years
16%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Other Long-Term Assets
$4.5B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
37%
|
CAGR 10-Years
28%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Other Long-Term Assets
$1.2B
|
CAGR 3-Years
51%
|
CAGR 5-Years
42%
|
CAGR 10-Years
27%
|
|
|
Stryker Corp
NYSE:SYK
|
Other Long-Term Assets
$3.8B
|
CAGR 3-Years
7%
|
CAGR 5-Years
9%
|
CAGR 10-Years
23%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Other Long-Term Assets
$1.4B
|
CAGR 3-Years
22%
|
CAGR 5-Years
16%
|
CAGR 10-Years
27%
|
See Also
What is Abbott Laboratories's Other Long-Term Assets?
Other Long-Term Assets
7.1B
USD
7.1B
USD
Based on the financial report for Dec 31, 2023, Abbott Laboratories's Other Long-Term Assets amounts to 7.1B USD.
What is Abbott Laboratories's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 10Y
13%
13%
Over the last year, the Other Long-Term Assets growth was 18%. The average annual Other Long-Term Assets growth rates for Abbott Laboratories have been 24% over the past three years , 30% over the past five years , and 13% over the past ten years .
You don't have any saved screeners yet
